leisure time -WSS

leisure time

author：knowledge 2025-09-27 22:50:00 - browse：19956

Adam's take main illustration — Molly Ferguson/STAT

This week, a preview of the TUDCA study in ALS and thoughts on how it might impact Amylyx Pharmaceuticals. Also, I chatted with CRISPR Therapeutics CEO Sam Kulkarni about its new investor. Read to the end for some burning questions, random thoughts.

The next ALS data readout — overdue but important

A European academic consortium is expected to announce results soon from a clinical trial investigating the use of a widely available nutritional supplement called tauroursodeoxycholic acid, or TUDCA, in people living with ALS. The outcome of the TUDCA-ALS study could have implications for Amylyx Pharmaceuticals, because TUDCA is one of the two main ingredients in Relyvrio, the company’s approved drug for ALS.

In a recent interview at Amylyx’s Kendall Square headquarters, co-CEOs Justin Klee and Josh Cohen mostly downplayed the suggestion that results from the randomized, placebo-controlled TUDCA study might affect Relyvrio negatively, or even positively.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： With Wegovy coverage, Medicare patients may face high costs

focus

hotspot

WSS

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

The Bio Revolution is changing business and society

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

Should insurance cover cosmetic surgery?

Bird flu makes raw milk dangerous to consume, mouse study finds

hotspot

leisure time

The next ALS data readout — overdue but important

explore

Trump demands the U.S. pay no more for drugs than other countries … again

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

'Patient friction coefficient' can gauge a clinical trial's patient burden

Alkermes shareholders re

Pregnancy ages women, but effects reverse after delivery

Anesthesiologist group: stop taking Ozempic before surgery

Pregnancy ages women, but effects reverse after delivery

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Diabetes management: Digital health tools fall short, study says

entertainment

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

Readout Newsletter: Illumina, CRISPR, Regeneron

Bird flu makes raw milk dangerous to consume, mouse study finds

Adam's Take: Intra

Guardant Health colon cancer test endorsed by FDA advisory panel

The world needs the new pandemic treaty

focus

hotspot

focus

hotspot